0KRP4KZ
Replacement Hip Muscle, Left to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | K Muscles |
| Operation | R Replacement |
| Body Part | P Hip Muscle, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
Replacement procedures put in biological or synthetic material that physically takes over for muscle tissue that has been lost or is not present, such as after extensive trauma, tumor resection, or a congenital absence. Materials used can include a graft of the patient's own tissue, donor tissue, or a synthetic implant shaped to substitute for the missing muscle bulk or function. This differs from simply patching a hole, since the intent is for the new material to serve in place of the muscle going forward.
These procedures are reserved for situations where enough native muscle is missing that repair alone would not restore adequate function or contour, such as reconstructive surgery following cancer removal or a severe crush injury. Recovery generally involves protecting the graft or implant site while it integrates.
Anatomy & Axis Detail
Hip Muscle, Left
Replacement of the left hip muscle involves grafting or synthetic substitution of gluteal, iliopsoas, or short rotator tissue, commonly performed when tumor excision, chronic avulsion, or failed revision arthroplasty leaves the native muscle unable to stabilize the joint. The left hip abductors in particular counteract pelvic drop during ambulation, so their replacement is frequently paired with reconstruction of the greater trochanter or hip capsule. Documentation should clearly indicate laterality and the specific muscle replaced, since this procedure is distinct from tendon transfer or simple repair of a partial tear.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
A Replacement code requires documentation that material was put in to physically take the place of muscle tissue, along with the type of material used, since the character of the substitute, whether autologous graft, nonautologous tissue, or synthetic, determines the correct qualifier. The note should make clear that tissue is being substituted for, not merely reinforced or supported.
The most common error is applying Replacement when a mesh or patch was used only to reinforce or support existing muscle rather than to take its place, which should instead be coded as Supplement. Coders should also verify the source of the graft material carefully, since autologous versus nonautologous versus synthetic material changes the code assigned.